醒神开窍合剂对颅脑损伤大鼠运动功能及自噬相关蛋白Beclin1、LC3-Ⅱ表达的影响OA
Effects of Xingshen Kaiqiao Compounds on Motor Function and Expression of Autophagy-Related Proteins Beclin1 and LC3-Ⅱ in Rats with Traumatic Brain Injury
目的:观察醒神开窍合剂对颅脑损伤大鼠运动功能及自噬相关蛋白Beclin1、LC3-Ⅱ蛋白表达的影响.方法:将30只雄性SD大鼠随机分为假手术组、模型组、醒神开窍合剂组各10只,模型组、醒神开窍合剂组均采用控制性皮质撞击法复制大鼠大颅脑损伤模型,假手术组仅给予皮肤切开、暴露颅骨,不进行打击;造模后醒神开窍合剂组给予灌胃醒神开窍合剂(5.99 g/kg,分3次给药),假手术组及模型组给予灌胃等量生理盐水,三组均连续干预7天.分别于干预后3天、7天记录各组大鼠神经功能损伤评分(mNSS),并进行滚轮运动试验评价大鼠运动功能;干预7天后,采用试剂盒法检测各组大鼠血清乳酸脱氢酶(Lactate De-hydrogenase,LDH)释放率,HE染色法评估各组大鼠神经组织形态学变化,Western Blot法检测大鼠损伤脑组织巢蛋白(Nestin)、胶质纤维酸性蛋白(glial fibrillary acidic protein,GFAP)及自噬蛋白Beclin1、LC3-Ⅱ的表达水平.结果:mNSS评分显示,干预3天后,模型组和醒神开窍合剂组显著高于假手术组(P<0.01),而模型组和醒神开窍合剂组之间无显著性差异(P>0.05);干预7天后,模型组和醒神开窍合剂组显著高于假手术组(P<0.05,P<0.01),醒神开窍合剂组低于模型组(P<0.05).转棒实验评分结果显示,干预3天后,模型组和醒神开窍合剂组显著低于假手术组(P<0.01),而模型组和醒神开窍合剂组之间无显著性差异(P>0.05);干预7天后,模型组和醒神开窍合剂组显著低于假手术组(P<0.05,P<0.01),醒神开窍合剂组有高于模型组的趋势,但无显著性差异(P>0.05).LDH释放率结果显示,与假手术组相比,模型组血清LDH释放率显著升高(P<0.05);与模型组比较,醒神开窍合剂组LDH释放率显著降低(P<0.05);醒神开窍合剂组与假手术组之间LDH释放率无显著性差异(P>0.05).HE结果显示,假手术组脑组织细胞排列整齐,形态正常;TBI模型组大鼠细胞排列紊乱,形态不规则,部分细胞细胞核固缩深染;醒神开窍合剂组大鼠脑组织较模型组大鼠形态变规则、排列整齐,细胞核固缩深染程度减轻.Western-blot结果显示,与假手术组相比,模型组Beclin1、LC3-Ⅱ蛋白表达显著升高(P<0.05),GFAP、Nestin蛋白表达有下降的趋势,但无显著性差异(P>0.05);与模型组相比,醒神开窍合剂组GFAP、Nestin蛋白表达显著升高(P<0.05),Beclin1、LC3-Ⅱ蛋白表达显著下降(P<0.05);醒神开窍合剂组与假手术组在Nestin、GFAP、Beclin1、LC3-Ⅱ蛋白的表达方面均无显著性差异(P>0.05).结论:醒神开窍合剂可提高损伤脑组织Nestin、GFAP蛋白的表达,降低血清LDH释放率及自噬蛋白Beclin1、LC3-Ⅱ的表达,改善颅脑损伤后大鼠肢体功能.
Objective:To investigate the effects of Xingshen Kaiqiao Compounds(XKC)on motor function and the expression of autophagy-related proteins Beclin1 and LC3-II in rats with traumatic brain injury(TBI).Methods:Thirty male Sprague-Dawley(SD)rats were randomly divided into three groups(n=10 per group):sham group,model group,and XKC group.The model and XKC groups were subjected to TBI using a pneumatic impact method,while the sham group underwent skin incision and skull exposure without impact.After modeling,the XKC group received intragastric administration of XKC(5.99 g/kg,divided into three doses daily),while the sham and model groups received equivalent volumes of saline.At 3 and 7 days after intervention,neurological function deficits were assessed using the modified Neurological Severity Score(mNSS),and motor function was evaluated via the rotarod test.After 7 days of intervention,serum lactate dehydrogenase(LDH)release rate was measured using a commercial kit.Hematoxylin-eosin(HE)staining was performed to assess neurohistological changes.Western blotting was used to detect the expression of Nestin,glial fibrillary acidic protein(GFAP),Beclin1,and LC3-II in injured brain tissues.Results:(1)mNSS evaluation results showed that on day 3 after intervention,both the model group and XKC group had significantly higher scores than the sham group(P<0.01),with no significant difference between the model and XKC groups(P>0.05).By day 7,the model and XKC groups remained significantly higher than the sham group(P<0.05,P<0.01),but the XNKQ group exhibited lower scores than the model group(P<0.05).(2)Rotarod test results demonstrated that on day 3,both the model and XKC groups had significantly lower scores than the sham group(P<0.01),with no difference between the two groups(P>0.05).By day 7,the model and XKC groups remained lower than the sham group(P<0.05,P<0.01),though the XNKQ group showed a trend toward higher scores than the model group,without statistical significance(P>0.05).(3)LDH release rate:Compared with the sham group,the model group showed significantly increased serum LDH release(P<0.05).The XKC group exhibited a marked reduction in LDH release compared to the model group(P<0.05),with no significant difference between the XKC and sham groups(P>0.05).(4)HE staining:The sham group displayed normal neuronal morphology with orderly cell arrangement.The TBI model group showed disordered cell arrangement,irregular morphology,and pyknotic nuclei.The XKC group demonstrated improved histological structure,with more regular cell arrangement and reduced nuclear pyknosis compared to the model group.(5)Western blot:Compared to the sham group,Beclin1 and LC3-II expression was significantly upregulated in the model group(P<0.05),while GFAP and Nestin expression showed a downward trend without statistical significance(P>0.05).Compared to the model group,the XKC group showed significantly increased GFAP and Nestin expression(P<0.05)and decreased Beclin1 and LC3-II expression(P<0.05).No significant differences were observed between the XKC and sham groups in Nestin,GFAP,Beclin1,or LC3-II expression(P>0.05).Conclusion:Xingshen Kaiqiao Compounds may improve limb function in TBI rats by enhancing the expression of Nestin and GFAP in injured brain tissues,reducing serum LDH release and autophagy-related proteins Beclin1 and LC3-II.
LIU Tong;LI Wenmin;KUANG Weichuan;LIU Yue;LV Zongze;WANG Dilin;XU Xiaolin;CHEN Ying;LI Huixian;XIE Miao;GAO Luming;HUANG Zhibin
The Fifth Clinical Medical College,Guangzhou University of Chinese Medicine,Guangzhou,Guangdong 510095||Guangdong Second Hospital of Traditional Chinese Medicine/Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine,Guangzhou,Guangdong 510095The Fifth Clinical Medical College,Guangzhou University of Chinese Medicine,Guangzhou,Guangdong 510095The Fifth Clinical Medical College,Guangzhou University of Chinese Medicine,Guangzhou,Guangdong 510095||Guangdong Second Hospital of Traditional Chinese Medicine/Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine,Guangzhou,Guangdong 510095The Fifth Clinical Medical College,Guangzhou University of Chinese Medicine,Guangzhou,Guangdong 510095||Guangdong Second Hospital of Traditional Chinese Medicine/Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine,Guangzhou,Guangdong 510095The Fifth Clinical Medical College,Guangzhou University of Chinese Medicine,Guangzhou,Guangdong 510095The Fifth Clinical Medical College,Guangzhou University of Chinese Medicine,Guangzhou,Guangdong 510095The Fifth Clinical Medical College,Guangzhou University of Chinese Medicine,Guangzhou,Guangdong 510095The Fifth Clinical Medical College,Guangzhou University of Chinese Medicine,Guangzhou,Guangdong 510095The Fifth Clinical Medical College,Guangzhou University of Chinese Medicine,Guangzhou,Guangdong 510095The Fifth Clinical Medical College,Guangzhou University of Chinese Medicine,Guangzhou,Guangdong 510095The Fifth Clinical Medical College,Guangzhou University of Chinese Medicine,Guangzhou,Guangdong 510095The Fifth Clinical Medical College,Guangzhou University of Chinese Medicine,Guangzhou,Guangdong 510095
医药卫生
醒神开窍合剂颅脑损伤自噬Beclin1LC3-Ⅱ
Xingshen Kaiqiao compoundstraumatic brain injuryautophagyBeclin1LC3-Ⅱ
《中医康复》 2026 (1)
56-63,8
广东省自然基金面上项目(2022A1515011676)广东省自然基金省企联合基金(2022A1515220012,2023A1515220086)广东省第二中医院青年培优计划项目中央财政转移支付地方项目(602023057)2024广东省刘悦名中医工作室建设项目(粤中医办函[2023]108号)
评论